Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Lilly backs $45M investment for mRNA cancer immunotherapy startup
Businesswire
Mon, 11/28/22 - 10:16 am
Strand Therapeutics
funding
Eli Lilly
rRNA
cancer
Biggest drug companies halted Twitter ad buys after Lilly insulin spoof
Endpoints
Mon, 11/21/22 - 06:38 pm
twitter
social media
pharma ads
Eli Lilly
Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report
Endpoints
Mon, 11/21/22 - 06:34 pm
Eli Lilly
Mounjaro
diabetes
type 2 diabetes
drug manufacturing
Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds
MedCity News
Sun, 11/20/22 - 12:37 pm
Acrivon Therapeutics
Eli Lilly
IPOs
Proteomics
cancer
oncology
Lilly wins FDA approval for second interchangeable insulin biosimilar
Endpoints
Thu, 11/17/22 - 11:27 pm
Eli Lilly
FDA
insulin
diabetes
biosimilars
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Roche
Alzheimer's disease
gantenerumab
Biogen
Cassava Sciences
Eli Lilly
Fake Eli Lilly Twitter account falsely claimed insulin 'free'
Indianapolis Star, IN
Fri, 11/11/22 - 10:50 am
Eli Lilly
social media
insulin
twitter
Elon Musk
Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight
Fierce Pharma
Thu, 11/10/22 - 10:12 pm
Eli Lilly
legal
migraines
Ajovy
patents
Lilly’s new diabetes management platform to integrate Dexcom CGM
Medtech Dive
Wed, 11/9/22 - 10:44 am
Eli Lilly
diabetes
DexCom
Medtech
devices
Tempo
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Amgen
obesity
Eli Lilly
Novo Nordisk
AMG 133
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Eli Lilly
Boehringer Ingelheim
chronic kideny disease
Jardiance
Farxiga
AstraZeneca
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Xtalks
Thu, 11/3/22 - 07:25 pm
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
type 2 diabetes
Lilly sales of new diabetes drug accelerate on rising patient demand
BioPharma Dive
Tue, 11/1/22 - 07:10 pm
Eli Lilly
diabetes
Mounjaro
patients
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
Tue, 11/1/22 - 07:09 pm
gene therapy
M&A
Akouos
AGTC
Taysha Gene Therapies
Astellas
Eli Lilly
Syncona
Lilly powers through final stretch in critical Alzheimer's race
Fierce Biotech
Tue, 11/1/22 - 07:02 pm
Eli Lilly
Alzheimer's disease
donanemab
lecanemab
Eisai
Eli Lilly revenue inches up 2%, Pfizer raises full year outlook
Medical Marketing and Media
Tue, 11/1/22 - 11:02 am
Eli Lilly
Pfizer
earnings
Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
Mon, 10/31/22 - 10:37 am
clinical trials
systemic lupus erythematosus
AbbVie
ABBV-509
Eli Lilly
LY3471851
Merck KGaA
M5049
Swedish Orphan Biovitrum
emapalumab
Eli Lilly commits $92.5M to Purdue University for pharmaceutical manufacturing scholarships
Layfette Journal and Courier, IN
Fri, 10/28/22 - 10:30 am
Eli Lilly
philanthropy
drug manufacturing
Purdue University
Just announced: upcoming late-stage clinical trials in weight loss and diabetes
Clinical Trials Arena
Sun, 10/23/22 - 07:09 pm
clinical trials
Eli Lilly
Novo Nordisk
weight loss
diabetes
Ozempic
Wegovey
Mounjaro
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »